Influence of multiple nasal administrations of bioadhesive powders on the insulin bioavailability

被引:28
作者
Callens, C [1 ]
Pringels, E [1 ]
Remon, JP [1 ]
机构
[1] State Univ Ghent, Fac Pharmaceut Sci, Pharmaceut Technol Lab, B-9000 Ghent, Belgium
关键词
multiple administration; bioavailability; nasal drug delivery; insulin; bioadhesion;
D O I
10.1016/S0378-5173(02)00555-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peptides and more especially insulin are mainly used in therapies that need multiple drug administration. As peptides are highly potent, it is required that their bioavailability remains constant even during a long term administration. In this study, the bioavailability and blood glucose levels are reported after multiple nasal administration of insulin via two bioadhesive platforms consisting of a cospray dried mixture of Amioca((R)) starch and Carbopol((R)) 974P (1/3) and a physical mixture of drum dried waxy maize starch and Carbopol((R)) 974P (9/1), respectively. The experiments were performed in rabbits and the formulations were administered during 8 consecutive days. The bioavailability and the maximal decrease of the blood glucose level were determined on the first and last day of the insulin administration. These two parameters were decreased on the eighth day compared with the first day of administration. When the formulations were not administered from day 2 until day 7, the bioavailability on the eighth day compared with the first day of administration was not modified. It was concluded that daily administrations of the bioadhesive formulations affected the nasal bioavailability of insulin in rabbits. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:415 / 422
页数:8
相关论文
共 20 条
[1]   Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol® 974 P on rabbit nasal mucosa and slug mucosa [J].
Callens, C ;
Adriaens, E ;
Dierckens, K ;
Remon, JP .
JOURNAL OF CONTROLLED RELEASE, 2001, 76 (1-2) :81-91
[2]   Evaluation of starch-maltodextrin-Carbopol® 974 P mixtures for the nasal delivery of insulin in rabbits [J].
Callens, C ;
Remon, JP .
JOURNAL OF CONTROLLED RELEASE, 2000, 66 (2-3) :215-220
[3]   NASAL ABSORPTION IN THE RAT .3. EFFECT OF LYSOPHOSPHOLIPIDS ON INSULIN ABSORPTION AND NASAL HISTOLOGY [J].
CHANDLER, SG ;
THOMAS, NW ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (11) :1623-1630
[4]  
CORNAZ AL, 1994, EUR J PHARM BIOPHARM, V40, P261
[5]   IN-VIVO EVALUATION OF SPRAY FORMULATIONS OF HUMAN INSULIN FOR NASAL DELIVERY [J].
DONDETI, P ;
ZIA, HS ;
NEEDHAM, TE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 122 (1-2) :91-105
[6]   MICROSPHERES AS A NASAL DELIVERY SYSTEM FOR PEPTIDE DRUGS [J].
EDMAN, P ;
BJORK, E ;
RYDEN, L .
JOURNAL OF CONTROLLED RELEASE, 1992, 21 (1-3) :165-172
[7]  
EDMAN P, 1992, ADV DRUG DELIVER REV, V8, P165, DOI 10.1016/0169-409X(92)90001-7
[8]  
EULEMANS J, 2002, PHARMAZIE, V57, P181
[9]   Enhancement of nasal absorption of insulin using chitosan nanoparticles [J].
Fernández-Urrusuno, R ;
Calvo, P ;
Remuñán-López, C ;
Vila-Jato, JL ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1576-1581
[10]   THE RELEVANCE OF NASAL PHYSIOLOGY TO THE DESIGN OF DRUG ABSORPTION STUDIES [J].
GIZURARSON, S .
ADVANCED DRUG DELIVERY REVIEWS, 1993, 11 (03) :329-347